Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same

Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same

US Patent 11224665 · Granted Jan 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2024
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2024
Niclosamide analogues and therapeutic use thereof2024
Cancer vaccines and methods of delivery2022
Cancer vaccines and methods of delivery2022
Vaccines against antigens involved in therapy resistance and methods of using sa2022
Vaccines against antigens involved in therapy resistance and methods of using sa2022
Chemical modulators of signaling pathways and therapeutic use2021
Vaccines against an oncogenic isoform of ESR1 and methods of using the same2020
Vaccines against an oncogenic isoform of ESR1 and methods of using the same2020
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2020
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2020